I'm an adult in the United States and I was always told that men can't be tested for HPV -- thus there's no way of knowing if one's partner is infected. The JID study clearly suggests otherwise. Why is screening for HPV not possible for men in the US?
*Infectious Disease Puscast #66: Literature Review (October 8-23, 2024)* * *0:00** Introduction:* Daniel Griffin and Sarah Dong review infectious disease literature from the past two weeks. * *1:57** Viral:* * *1:57** HPV Prevalence in Danish Men:* A study in the Journal of Infectious Diseases (JID) found that a girls-only HPV vaccination program significantly reduced HPV prevalence in young men, particularly for high-risk types. However, overall prevalence remains high due to less carcinogenic types, suggesting potential benefits of gender-neutral vaccination. * *4:57** HIV Primary Care Guidance Update:* The HIV Medicine Association (HIVMA) and Infectious Diseases Society of America (IDSA) released updated primary care guidance for people with HIV, including expanded sections on patient-centered care, immunizations, cancer screening, STIs, and metabolic disease. * *7:22** Bacterial:* * *7:22** Linezolid vs. Clindamycin for Invasive Group A Strep:* A retrospective study in Lancet Infectious Diseases compared linezolid and clindamycin as adjunctive therapy to beta-lactams for invasive group A strep. The study found no significant difference in in-hospital mortality or C. difficile infection. * *12:52** Tapered vs. Standard Vancomycin for C. difficile:* A retrospective study in Infection Control and Hospital Epidemiology found that a 12-week tapered oral vancomycin regimen significantly reduced C. difficile recurrence compared to standard 10-14 day therapy. * *16:51** Oral Vancomycin Prophylaxis for C. difficile in Autologous Stem Cell Transplant:* A study in Open Forum Infectious Diseases (OFID) evaluated primary oral vancomycin prophylaxis for C. difficile in autologous stem cell transplant recipients. It found a reduction in in-hospital C. difficile but no impact on post-discharge infection. * *19:54** Vibrio metoecus Septicemia:* JID reported the first fatal case of septicemia caused by Vibrio metoecus, highlighting the potential for emerging vibrio species to cause severe infections. * *22:06** Fungal:* * *22:06** Chromoblastomycosis Global Strategy:* PLoS Neglected Tropical Diseases published a paper on a global strategy to address chromoblastomycosis, a neglected fungal infection affecting agricultural workers in tropical and subtropical regions. * *25:45** Blastomycosis Outbreak in Michigan:* Clinical Infectious Diseases (CID) reported on a large blastomycosis outbreak at a paper mill in Michigan, highlighting the importance of early diagnosis and treatment. * *29:14** Candida auris Virulence and Variation:* PLoS Pathogens explored the role of phenotypic plasticity and interspecies variation in the virulence of Candida auris, suggesting a complex community strategy that allows the fungus to adapt to different environments. * *31:28** Parasitic:* * *31:28** Babesiosis Co-infection and Mortality:* OFID published a study on babesiosis co-infection prevalence and its association with mortality. Interestingly, co-infection was associated with lower mortality, possibly due to increased medical attention for co-infected individuals. * *34:29** New WHO Guidelines for Rhodesiense HAT:* Lancet Infectious Diseases announced new WHO guidelines for treating Rhodesiense human African trypanosomiasis (HAT), recommending fexinidazole and pentamidine as first-line therapies, replacing older drugs with potentially severe side effects. * *37:19** Miscellaneous:* * *37:19** Pediatric Infectious Disease Telemedicine:* JIDS published a study demonstrating the social and environmental benefits of pediatric infectious disease telemedicine, including reduced travel and improved access to care. * *40:07** Conclusion:* The hosts summarize the reviewed articles and encourage listeners to submit questions and suggestions. They also solicit support for the MicrobeTV podcasts. I used gemini-1.5-pro-exp-0827 on rocketrecap dot com to summarize the transcript. Cost (if I didn't use the free tier): $0.03 Input tokens: 22733 Output tokens: 844
I'm an adult in the United States and I was always told that men can't be tested for HPV -- thus there's no way of knowing if one's partner is infected. The JID study clearly suggests otherwise. Why is screening for HPV not possible for men in the US?
*Infectious Disease Puscast #66: Literature Review (October 8-23, 2024)*
* *0:00** Introduction:* Daniel Griffin and Sarah Dong review infectious disease literature from the past two weeks.
* *1:57** Viral:*
* *1:57** HPV Prevalence in Danish Men:* A study in the Journal of Infectious Diseases (JID) found that a girls-only HPV vaccination program significantly reduced HPV prevalence in young men, particularly for high-risk types. However, overall prevalence remains high due to less carcinogenic types, suggesting potential benefits of gender-neutral vaccination.
* *4:57** HIV Primary Care Guidance Update:* The HIV Medicine Association (HIVMA) and Infectious Diseases Society of America (IDSA) released updated primary care guidance for people with HIV, including expanded sections on patient-centered care, immunizations, cancer screening, STIs, and metabolic disease.
* *7:22** Bacterial:*
* *7:22** Linezolid vs. Clindamycin for Invasive Group A Strep:* A retrospective study in Lancet Infectious Diseases compared linezolid and clindamycin as adjunctive therapy to beta-lactams for invasive group A strep. The study found no significant difference in in-hospital mortality or C. difficile infection.
* *12:52** Tapered vs. Standard Vancomycin for C. difficile:* A retrospective study in Infection Control and Hospital Epidemiology found that a 12-week tapered oral vancomycin regimen significantly reduced C. difficile recurrence compared to standard 10-14 day therapy.
* *16:51** Oral Vancomycin Prophylaxis for C. difficile in Autologous Stem Cell Transplant:* A study in Open Forum Infectious Diseases (OFID) evaluated primary oral vancomycin prophylaxis for C. difficile in autologous stem cell transplant recipients. It found a reduction in in-hospital C. difficile but no impact on post-discharge infection.
* *19:54** Vibrio metoecus Septicemia:* JID reported the first fatal case of septicemia caused by Vibrio metoecus, highlighting the potential for emerging vibrio species to cause severe infections.
* *22:06** Fungal:*
* *22:06** Chromoblastomycosis Global Strategy:* PLoS Neglected Tropical Diseases published a paper on a global strategy to address chromoblastomycosis, a neglected fungal infection affecting agricultural workers in tropical and subtropical regions.
* *25:45** Blastomycosis Outbreak in Michigan:* Clinical Infectious Diseases (CID) reported on a large blastomycosis outbreak at a paper mill in Michigan, highlighting the importance of early diagnosis and treatment.
* *29:14** Candida auris Virulence and Variation:* PLoS Pathogens explored the role of phenotypic plasticity and interspecies variation in the virulence of Candida auris, suggesting a complex community strategy that allows the fungus to adapt to different environments.
* *31:28** Parasitic:*
* *31:28** Babesiosis Co-infection and Mortality:* OFID published a study on babesiosis co-infection prevalence and its association with mortality. Interestingly, co-infection was associated with lower mortality, possibly due to increased medical attention for co-infected individuals.
* *34:29** New WHO Guidelines for Rhodesiense HAT:* Lancet Infectious Diseases announced new WHO guidelines for treating Rhodesiense human African trypanosomiasis (HAT), recommending fexinidazole and pentamidine as first-line therapies, replacing older drugs with potentially severe side effects.
* *37:19** Miscellaneous:*
* *37:19** Pediatric Infectious Disease Telemedicine:* JIDS published a study demonstrating the social and environmental benefits of pediatric infectious disease telemedicine, including reduced travel and improved access to care.
* *40:07** Conclusion:* The hosts summarize the reviewed articles and encourage listeners to submit questions and suggestions. They also solicit support for the MicrobeTV podcasts.
I used gemini-1.5-pro-exp-0827 on rocketrecap dot com to summarize the transcript.
Cost (if I didn't use the free tier): $0.03
Input tokens: 22733
Output tokens: 844